Creative Planning
ARNA

Creative Planning’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Creative Planning’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,170
Closed -$87K – 4060
2017
Q2 		$87K Buy
5,170
+19
+0.4% +$261 ﹤0.01% 2082
2017
Q1 		$75K Buy
5,151
+900
+21% +$13.3K ﹤0.01% 2156
2016
Q4 		$60K Sell
4,251
-223
-5% -$3.45K ﹤0.01% 2252
2016
Q3 		$78K Buy
4,474
+120
+3% +$1.99K ﹤0.01% 2026
2016
Q2 		$74K Buy
4,354
+290
+7% +$5.18K ﹤0.01% 1865
2016
Q1 		$80K Buy
4,064
+350
+9% +$5.61K ﹤0.01% 1772
2015
Q4 		$71K Sell
3,714
-515
-12% -$10.5K ﹤0.01% 1847
2015
Q3 		$81K Sell
4,229
-518
-11% -$17.6K ﹤0.01% 1716
2015
Q2 		$220K Buy
4,747
+328
+7% +$14.2K ﹤0.01% 846
2015
Q1 		$193K Buy
4,419
+700
+19% +$32.5K ﹤0.01% 1205
2014
Q4 		$129K Sell
3,719
-236
-6% -$9.58K ﹤0.01% 1412
2014
Q3 		$166K Sell
3,955
-285
-7% -$12.7K ﹤0.01% 1167
2014
Q2 		$248K Buy
4,240
+1,130
+36% +$71.2K ﹤0.01% 929
2014
Q1 		$196K Buy
3,110
+1,243
+67% +$82.5K ﹤0.01% 1011
2013
Q4 		$109K Buy
1,867
+1,047
+128% +$54.7K ﹤0.01% 1154
2013
Q3 		$43K Buy
820
+50
+6% +$3.36K ﹤0.01% 1612
2013
Q2 		$59K Buy
+770
New +$62.9K ﹤0.01% 1299

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Creative Planning's ARNA Position: Q3 2017 in Review

Creative Planning sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2017, closing a stake of 5,170 shares — an estimated $87K sold.

Creative Planning first reported a position in ARNA in Q2 2013 and held it in 17 quarters. The position peaked at $248K in Q2 2014. 119 funds tracked by Wall St. Rank hold ARNA as of Q3 2017.

  • Creative Planning reported no remaining Arena Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 5,170 Arena Pharmaceuticals Inc shares in Q3 2017, an estimated $87K.
  • Creative Planning first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 17 quarters.
  • Creative Planning's Arena Pharmaceuticals Inc position peaked at $248K in Q2 2014.
  • 119 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.